CRYSTAL PACKING ANALYSIS SUGGESTS THAT A MONOMER IS THE STABLE OLIGOMERIC FORM IN SOLUTION. SEE REMARK 350 FOR INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S).
解像度: 2.5→27.661 Å / Num. obs: 10262 / % possible obs: 99.9 % / 冗長度: 5.4 % / Biso Wilson estimate: 71.685 Å2 / Rmerge(I) obs: 0.056 / Rsym value: 0.056 / Net I/σ(I): 9.491
反射 シェル
Diffraction-ID: 1
解像度 (Å)
冗長度 (%)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured all
Num. unique all
Rsym value
% possible all
2.5-2.56
5.6
0.779
1
4064
732
0.779
100
2.56-2.64
5.5
0.648
1.2
4020
730
0.648
100
2.64-2.71
5.5
0.542
1.4
3889
708
0.542
100
2.71-2.8
5.5
0.373
2
3804
686
0.373
100
2.8-2.89
5.5
0.274
2.8
3733
678
0.274
100
2.89-2.99
5.5
0.219
3.5
3467
627
0.219
100
2.99-3.1
5.5
0.162
4.7
3553
643
0.162
100
3.1-3.23
5.5
0.133
5.6
3305
602
0.133
100
3.23-3.37
5.5
0.087
8.5
3146
577
0.087
100
3.37-3.54
5.5
0.068
10.5
3069
558
0.068
100
3.54-3.73
5.5
0.061
10.2
2837
518
0.061
100
3.73-3.95
5.4
0.054
11.4
2801
515
0.054
100
3.95-4.23
5.5
0.05
11.1
2597
476
0.05
100
4.23-4.56
5.4
0.04
15
2386
441
0.04
100
4.56-5
5.4
0.034
18.3
2230
415
0.034
100
5-5.59
5.4
0.032
19.5
2001
373
0.032
100
5.59-6.45
5.3
0.04
15
1763
335
0.04
100
6.45-7.91
5.1
0.039
16.2
1457
284
0.039
100
7.91-11.18
5
0.026
24.1
1168
233
0.026
100
11.18-27.66
4.4
0.033
17.7
578
131
0.033
94.5
-
位相決定
位相決定
手法: 多波長異常分散
-
解析
ソフトウェア
名称
バージョン
分類
NB
REFMAC
5.2.0019
精密化
PHENIX
精密化
SOLVE
位相決定
MolProbity
3beta29
モデル構築
SCALA
3.2.5
データスケーリング
PDB_EXTRACT
3.006
データ抽出
MOSFLM
データ削減
精密化
構造決定の手法: 多波長異常分散 / 解像度: 2.5→27.661 Å / Cor.coef. Fo:Fc: 0.943 / Cor.coef. Fo:Fc free: 0.924 / Occupancy max: 1 / Occupancy min: 0.19 / SU B: 12.76 / SU ML: 0.14 / TLS residual ADP flag: LIKELY RESIDUAL / 交差検証法: THROUGHOUT / σ(F): 0 / ESU R: 0.274 / ESU R Free: 0.226 立体化学のターゲット値: MAXIMUM LIKELIHOOD WITH PHASES 詳細: 1.HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2.ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN ...詳細: 1.HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2.ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY. 3.A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4.AN UNIDENTIFIED LIGAND (UNL) HAS BEEN MODELED IN THE VICINITY OF THE PUTATIVE ACTIVE SITE BASED ON COMPARISON WITH LIGAND BOUND STRUCTURES OF SIMILAR PROTEINS. 5.A PEG FRAGMENT (P33, HEPTAETHYLENE GLYCOL, PEG330) FROM THE CRYSTALLIZATION CONDITION HAS BEEN MODELED IN THE SOLVENT STRUCTURE. 6.THERE ARE UNMODELED ELECTRON DENSITY BLOBS IN SEVERAL REGIONS OF THE PROTEIN INCLUDING RESIDUES H142/K143 AND D49. THESE RESIDUES ARE NOT IN THE VICINITY OF THE PUTATIVE ACTIVE SITE.
Rfactor
反射数
%反射
Selection details
Rfree
0.253
492
4.8 %
RANDOM
Rwork
0.219
-
-
-
obs
0.22
10246
99.91 %
-
溶媒の処理
イオンプローブ半径: 0.8 Å / 減衰半径: 0.8 Å / VDWプローブ半径: 1.2 Å / 溶媒モデル: MASK